Test May Find Early Sign of Neurological Disease
NYU Langone researchers find a simple test may determine whether a drop in blood pressure after standing is a sign of neurological disease.
Test Predicts Safety & Effectiveness of Cancer Immunotherapy
NYU Langone research test can predict which patients treated with immunotherapy are likely to have cancer recur or have severe side effects.
Testosterone Therapy Halves Risk of Prostate Cancer
In an NYU Langone study, men prescribed testosterone therapy for longer than a year had a 50 percent reduced risk of aggressive prostate cancer.
Thanksgiving Meal Kits Distributed at The Table Food Pantry
The Family Health Centers at NYU Langone and The Table Food Pantry distribute Thanksgiving meal kits with nutritious food to improve community health.
The 40 Gynecologic Cancer Questions Used to Query ChatGPT
A study led by NYU Langone experts queried the ChatGPT chatbot with 40 questions about genetic counseling and testing for genetic mutations and syndromes.
The ABCDEs of Melanoma Detection
Dermatologists at NYU Langone Health developed the criteria for detecting melanoma, popularized in the mnemonic ABCDE.
The Art of Caring for Patients with Skin of Color
NYU Langone’s Dr. Lisa O. Akintilo discusses dermatologic challenges for patients with skin of color and special services offered to meet their needs.
The Ballet Dancer Whose Torn ACL Threatened Her Career
When a knee injury paused her dance career, Manuela headed to Dr. Michael J. Alaia at NYU Langone’s Sports Medicine Center for treatment and rehab.
The Benefits of ‘Prehab’ Before Surgery
Prehabilitation before surgery may improve outcomes, NYU Langone physiatrist Dr. Jonathan H. Whiteson tells U.S. News & World Report.
The Benefits of TAVR for Cardiac Patients at All Risk Levels
NYU Langone’s Dr. Mathew Williams and the Heart Valve Center team play a key role as FDA approves TAVR for cardiac patients at all risk levels.